Predicting positivity for a new era of Alzheimer disease prevention trials
Neurology
.
2012 Oct 9;79(15):1530-1.
doi: 10.1212/WNL.0b013e31826e26db.
Epub 2012 Sep 12.
Authors
Jeffrey M Burns
,
William E Klunk
PMID:
22972636
DOI:
10.1212/WNL.0b013e31826e26db
No abstract available
Publication types
Editorial
Comment
MeSH terms
Amyloid / metabolism*
Brain / metabolism*
Female
Humans
Male
Substances
Amyloid
Grants and funding
P30 AG035982/AG/NIA NIH HHS/United States
R01 AG033673/AG/NIA NIH HHS/United States
P50 AG005133/AG/NIA NIH HHS/United States
P01 AG025204/AG/NIA NIH HHS/United States
R01 AG034614/AG/NIA NIH HHS/United States
R37 AG025516/AG/NIA NIH HHS/United States
UL1 TR000001/TR/NCATS NIH HHS/United States
RF1 AG025516/AG/NIA NIH HHS/United States
U10 NS077356/NS/NINDS NIH HHS/United States